Dibenz-(b,f)-1,4-oxazephine

Dibenz-(b,f)-1,4-oxazephine  Structure
CAS No.
257-07-8
Chemical Name:
Dibenz-(b,f)-1,4-oxazephine
Synonyms
EA-3547;DIBENZ-1,4-OXAZEPINE;DIBENZO(B,F)-1,4OXAZEPINE;dibenz(b,f)(1,4)oxazepine;benzo[b][1,4]benzoxazepine;benzo[b][1,5]benzoxazepine;Benzo [b,f][1,4] oxazepines;Dibenz-(b,f)-1,4-oxazephine
CBNumber:
CB8947048
Molecular Formula:
C13H9NO
Molecular Weight:
195.22
MOL File:
257-07-8.mol
MSDS File:
SDS
Modify Date:
2022/12/21 16:56:50

Dibenz-(b,f)-1,4-oxazephine Properties

Melting point 68-69 °C
Boiling point 331.88°C (rough estimate)
Density 1.1266 (rough estimate)
refractive index 1.6060 (estimate)
pka 0.50±0.70(Predicted)
EPA Substance Registry System Dibenz[b,f][1,4]oxazepine (257-07-8)

Dibenz-(b,f)-1,4-oxazephine Chemical Properties,Uses,Production

Description

Agent CR, dibenz-(b,f)-1,4-oxazepine, is a pale-yellow, crystalline solid, which has a melting point of 163°F (72°C). It has a pepper-like odor and is only used in solution for dissemination in liquid dispensers. Solutions consist of 0.1% of CR in 80 parts of propylene glycol and 20 parts water. CR is an eye irritant in organic solutions at concentrations of 0.0025% or lower. Agent CR is less toxic when inhaled, but has more profound skin effects, which are longer lasting. It is a persistent agent when released in the environment and deposited on clothing.

General Description

Colorless liquid, odorless to fruity.

Reactivity Profile

As an amine, Dibenz-(b,f)-1,4-oxazephine probably behaves less as a base than other aliphatic amines as due to Dibenz-(b,f)-1,4-oxazephine cyclic structure. However Dibenz-(b,f)-1,4-oxazephine will react as a weak base.

Health Hazard

Median incapacitating dose: 0.15. Eye/skin toxicity: Highly irritating; not toxic. Rate of action: Instantaneous. Physiological action: Irritates skin, eyes, nose, and throat. Detoxification rate: Moderate. (ANSER)

Safety Profile

Poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion and inhalation. Experimental teratogenic and reproductive effects. A human skin and eye irritant. Questionable carcinogen with experimental carcinogenic and tumorigenic data. When heated to decomposition it emits toxic fumes of NOx.

Dibenz-(b,f)-1,4-oxazephine Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 14)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
A. B. Enterprises +91-8048077585 Mumbai, India 1396 58 Inquiry
Dayang Chem (Hangzhou) Co.,Ltd. 571-88938639 +8617705817739 China 52861 58 Inquiry
GIHI CHEMICALS CO.,LIMITED +8618058761490 China 49999 58 Inquiry
Shanghai Likang New Materials Co., Limited +86-16631818819 +86-17736933208 China 9311 58 Inquiry
Hubei Enxing Biotechnology Co., Ltd 16621771607 China 8329 58 Inquiry
Amatek Scientific Co. Ltd. 0512-56316828 China 28819 58 Inquiry
Eurolabs Limited 44 1625 850089 United Kingdom 6323 46 Inquiry
Waterstone Technology, LLC 317 644 0862 United States 6801 30 Inquiry
Lanospharma Laboratories Co.,Ltd 13440048448 China 6343 56 Inquiry
Ryan Scientific, Inc. 843-884-4911 x 319 United States 6446 60 Inquiry
DIBENZO(B,F)-1,4OXAZEPINE DIBENZ-1,4-OXAZEPINE EA-3547 Dibenz-(b,f)-1,4-oxazephine dibenz(b,f)(1,4)oxazepine benzo[b][1,5]benzoxazepine benzo[b][1,4]benzoxazepine Benzo [b,f][1,4] oxazepines 257-07-8